-
As this issue of Bioterrorism Watch went to press, the Centers for Disease Control and Prevention (CDC) was investigating a case of ricin exposure in Las Vegas. The CDC said "preliminary results of environmental testing at laboratories in Nevada have tested positive for ricin."
-
The Centers for Disease Control and Prevention is distributing a new-generation smallpox vaccine, ACAM2000 (Acambis, Inc.; Cambridge, MA), to civilian laboratory personnel, the military, and state public health preparedness programs.
-
An exercise designed to test laboratory readiness for a bioterrorism incident turned into a real-life disaster of another sort when specimen mislabeling and flagrant breaches in infection control resulted in numerous exposures to an attenuated vaccine strain of Brucella abortus RB51, the Centers for Disease Control and Prevention reports.
-
As the number of high-containment labs undergoes an unprecedented expansion in the United States, the question of relative risk is coming to the forefront.
-
A rapid, ongoing expansion in the number of high-containment biodefense laboratories throughout the nation is raising serious questions about the safety of lab workers, the risk to the public, and the lack of government oversight to prevent accidents and security breaches.
-
Americans use many medications for countless medical conditions, spending about $100 billion annually. Unfortunately, partly because we use so many medications, medication error has become an important medical topic in the 21st century.
-
-
Federal and state funding for family planning client services reached $1.85 billion in FY 2006, a 63% increase over 12 years, adjusting for inflation.
-
A multidrug-resistant variant of community-acquired methicillin-resistant Staphylococcus aureus (MRSA) bacteria is emerging in cities on both coasts of the United States, according to data from a new California-led study.
-
Patients seeking medication abortion using mifepristone (Mifeprex, Danco Group) may be asking questions after news agencies reported leukemia drug safety issues at a Chinese drug manufacturing firm that serves as the sole U.S. supplier of mifepristone.